Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-065068

EVP, Research & CSO sold 3,805 shares at $31.19 ($118,683)

  • EVP, Research & CSO acquired 3,805 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-12-22 Option exercise +3,805 $1.53 $5,822 27,505 D
Virgin Herbert EVP, Research & CSO 2020-12-22 Sale −3,805 $31.19 $118,683 23,700 D
Derivatives
Virgin Herbert EVP, Research & CSO 2020-12-22 Option exercise · Stock Option (Right to Buy) −3,805 435,290 D
Open-market sales · 3,805 sh · avg $31.19 · $118,683
Loading xslF345X03/doc4.xml…